CClinicalTrials.gg
CompletedNCT07310329VitD-FootballUpdated Dec 30, 2025

High-Dose Vitamin D Supplementation and Exercise Effects on Vitamin D Metabolites in Professional Football Players

An interventional study of Vitamin D₃ and Placebo in Vitamin D Deficiency (10 ng/mL to 30 ng/mL), Athletes and Football Players, sponsored by Wroclaw University of Health and Sport Sciences. Completed at 1 site in Poland. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-30.

Sponsored by Wroclaw University of Health and Sport Sciences · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Apr 2024, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Male
01

Study summary

This randomized, single-blind, placebo-controlled pilot study investigated the effects of high-dose vitamin D₃ supplementation and football-specific physical exercise on vitamin D metabolite concentrations in professional male football players. The study aimed to evaluate the acute response of circulating vitamin D metabolites, including 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃, following a single oral dose of 500,000 IU cholecalciferol combined with high-intensity intermittent exercise typical of competitive football.

Twenty professional football players from a Polish top-division club participated in the study. Participants were randomly assigned to either the supplementation group (SGP) receiving 500,000 IU of vitamin D₃ or the placebo group (PGP) receiving an identical volume of placebo oil. The intervention was administered 48 hours prior to an intra-squad game. Blood samples were collected at three time points: baseline (T3), pre-match (T4), and post-match (T5). The primary outcome was the change in serum 25-(OH)D₃ concentration. Secondary outcomes included changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, as well as their ratios. The study also assessed whether physical exercise modulates vitamin D metabolism.

The findings demonstrated that high-dose vitamin D₃ supplementation significantly increased serum 25-(OH)D₃ (↑198%) and 3-epi-25-(OH)D₃ (↑444%) levels, while football-specific exercise itself induced moderate increases in vitamin D metabolites. The results suggest that skeletal muscle may play a key role in vitamin D storage and release in response to exercise. The supplementation was well tolerated, with no adverse events observed.

Read the detailed description

This pilot study was designed to explore the combined effects of high-dose vitamin D₃ supplementation and acute physical exercise on vitamin D metabolism in professional football players. The study responds to growing scientific interest in understanding how vitamin D status influences performance, recovery, and muscle function in athletes. While most previous studies have focused on chronic, low-to-moderate supplementation, this trial examined the response to a single, pharmacological dose of cholecalciferol in a controlled experimental setting.

Study Design

The study employed a randomized, single-blind, placebo-controlled, parallel-group design. Participants were randomly assigned to one of two groups:

Supplementation Group (SGP) - received a single oral dose of 500,000 IU vitamin D₃ (Vigantol Oil, P\&G Health, Germany);

Placebo Group (PGP) - received an identical amount of placebo (vegetable oil).

The supplementation was administered 48 hours before a standardized intra-squad football match (ISG), conducted under conditions simulating a competitive game. All players followed the same training schedule and diet during the study.

Participants

A total of 20 professional male football players (aged 18-35) from a Polish top-league club volunteered to participate. Inclusion criteria included active professional status, regular training participation, and no use of vitamin D or calcium supplements in the previous 3 months. Exclusion criteria included musculoskeletal injuries, metabolic disorders, or refusal to sign informed consent.

Measurements

Blood samples were collected at three time points:

T3: baseline (before supplementation),

T4: 48 hours post-supplementation (pre-match),

T5: immediately after the intra-squad game.

Serum concentrations of 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃ were determined using LC-MS/MS. Additional biochemical variables (hemoglobin, glucose, testosterone, cortisol, ferritin, calcium, CK) were analyzed to monitor physiological status.

Outcomes

Primary Outcome: Changes in serum 25-(OH)D₃ concentrations after supplementation and exercise.

Secondary Outcomes: Changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, metabolite ratios.

Ethics

The study was approved by the Ethics Committee of the Wroclaw University of Health and Sport Sciences (Resolution No. 1/2024, March 1, 2024). All participants signed written informed consent.

02

Conditions studied

  • Vitamin D Deficiency (10 ng/mL to 30 ng/mL)
  • Athletes
  • Football Players
  • Exercise Physiology

Browse trials for

Keywords

  • 24,25-(OH)2D3
  • 3-epi-25-(OH)D3
  • dietary supplement
  • physical performance
  • athletes
03

In context

Vitamin D Deficiency

772 studies on the registry are indexed under Vitamin D Deficiency; 61 are open to participants now.

This study's enrollment of 20 is below the median of 77 across 564 interventional studies indexed under Vitamin D Deficiency.

Browse Vitamin D Deficiency studies →

Lead sponsor

Wroclaw University of Health and Sport Sciences is the lead sponsor of 44 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Male professional football players aged 18-35 years
  2. Actively training and competing in the Polish first football league
  3. No vitamin D or calcium supplementation during the previous 3 months
  4. No injuries or illnesses affecting participation

Exclusion criteria

Exclusion Criteria:

  1. Current musculoskeletal injury or illness
  2. Chronic metabolic, endocrine, or renal disorders
  3. Use of vitamin D or calcium supplements
  4. Refusal or inability to sign informed consent
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Supplementation Group (SGP)

    Participants in this group received a single oral dose of 500,000 IU of vitamin D₃ (Vigantol Oil, P\&G Health, Germany) 48 hours before the intra-squad football match (ISG). Blood samples were collected before supplementation and both before and after the ISG to evaluate changes in vitamin D metabolites.

    Dietary Supplement: Vitamin D₃

  • Placebo comparator
    Placebo Group (PGP)

    Participants in this group received a single oral dose of placebo oil identical in color and consistency to the vitamin D₃ solution. Blood samples were collected at the same time points as in the supplementation group to assess vitamin D metabolite changes.

    Other: Placebo

Interventions

  • Dietary supplementVitamin D₃

    A single oral dose of 500,000 IU vitamin D₃ (Vigantol Oil, P\&G Health, Germany) was administered 48 hours before the intra-squad football match to assess its acute effects on vitamin D metabolite concentrations.

  • OtherPlacebo

    A single oral dose of vegetable oil matching the vitamin D₃ solution in color and consistency was administered 48 hours before the intra-squad football match.

06

What researchers measure

Primary outcomes

  1. Changes in serum 25(OH)D₃ concentration

    Serum concentrations of 25(OH)D₃ will be measured using isotope-dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS). The primary outcome assesses the effect of a single high-dose vitamin D₃ supplementation combined with physical exercise on 25(OH)D₃ concentration in professional football players.

    Time frame: Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).

  2. Changes in serum 24,25-dihydroxyvitamin D₃ [24,25(OH)₂D₃] concentration

    To evaluate the effect of vitamin D₃ supplementation and physical exercise on 24,25(OH)₂D₃ levels using ID-LC-MS/MS.

    Time frame: Baseline (T3), 48 hours post-supplementation (T4), and post-exercise (T5)

Secondary outcomes

  1. Changes in metabolite ratios (25(OH)D₃:24,25(OH)₂D₃ and 25(OH)D₃:3-epi-25(OH)D₃)

    To assess changes in the ratios between major vitamin D metabolites as indicators of metabolic transformation rate and vitamin D turnover in response to supplementation and physical activity.

    Time frame: Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).

07

Study locations

1 site
  • Wroclaw University of Health and Sport Sciences
    Wroclaw, Dolnyśląsk 51-612, Poland
08

References and documents

Publications

  • Mieszkowski J, Stankiewicz B, Kochanowicz A, Niespodzinski B, Kowalik T, Zmijewski M, Kowalski K, Rola R, Bienkowski T, Antosiewicz J. Ultra-Marathon-Induced Increase in Serum Levels of Vitamin D Metabolites: A Double-Blind Randomized Controlled Trial. Nutrients. 2020 Nov 25;12(12):3629. doi: 10.3390/nu12123629. PubMed 33255807 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared due to privacy considerations and the specific nature of the study population (professional athletes). Aggregated data are available upon reasonable request to the corresponding author.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07310329
Lead sponsor
Wroclaw University of Health and Sport Sciences
Responsible party
Anna Książek (Associate Professor, Wroclaw University of Health and Sport Sciences) — Principal investigator
First posted
Dec 30, 2025
Start date
Apr 27, 2024
Primary completion
May 17, 2024
Completion
Jun 24, 2024
Last update
Dec 30, 2025

Study contacts

Anna Książek, PhD Eng.; Associate Professor
principal investigator · Department of Biological Principles of Physical Activity ; Wroclaw University of Health and Sport Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion